| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/12/2005 | CN1562063A Medicinal preparation containing erythromycine ethylsuccinate |
| 01/12/2005 | CN1562061A Tylan phosphate granular agent and its preparing method |
| 01/12/2005 | CN1562051A Clarithromycin release control tablet and method for administration and production thereof |
| 01/12/2005 | CN1562046A Adefovir dipivoil dispersion tablet and preparing method |
| 01/12/2005 | CN1562045A Doxycycline dripping pill |
| 01/12/2005 | CN1562040A Composition of cefuroxime and tazobatam |
| 01/12/2005 | CN1562031A Gatifloxacin gels and its preparing method |
| 01/12/2005 | CN1562029A Almitil intravenous injection and its preparing method |
| 01/12/2005 | CN1562017A Balofoxacin liquid preparation preparing method and its use |
| 01/12/2005 | CN1562016A Freeze-dried preparation containing balofoxacin and its use |
| 01/12/2005 | CN1561997A Medicinal composition having anti-inflammation and anti-infection function |
| 01/12/2005 | CN1561990A Treatment of immune diseases |
| 01/12/2005 | CN1561984A Novel sodium houttuyfonate effervescence tablet and its preparing method |
| 01/12/2005 | CN1561976A Garlicin concentrated, solution for supply intravenous after composite solvent dilution |
| 01/12/2005 | CN1184320C Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/12/2005 | CN1184233C Erytrocyte-stimulating factor coupling |
| 01/12/2005 | CN1184208C Substituted benzimidazoles and their prepn. and use |
| 01/12/2005 | CN1184205C Method for synthesizing pasiniazide |
| 01/12/2005 | CN1183964C Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir |
| 01/12/2005 | CN1183960C Use of bifidobacterium cell wall and bifidobacterium cell wall protein in pharmacy |
| 01/12/2005 | CN1183937C Compound Chinese medicine preparation of damnacanthus for treating hepatitis B |
| 01/12/2005 | CN1183934C Disinfectant |
| 01/12/2005 | CN1183916C Use of lactic acid bacterium for the treatment of peritonitis |
| 01/12/2005 | CN1183915C Medicine preparation for inhibiting immune deficiency syndrome virus infection and proliferation and its application |
| 01/12/2005 | CN1183910C Antibiotic medicine for injection |
| 01/12/2005 | CN1183901C Pharmaceutical compositions capable of being gelled |
| 01/11/2005 | US6841678 Hofmann degradation of amide to amine |
| 01/11/2005 | US6841664 Macrolides possessing a 3-oxo moiety in place of the 3-cladinose sugar. or "ketolides" have displayed significant in vitro and in vivo activity against H.influenzae and multiresistant pneumococci |
| 01/11/2005 | US6841567 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/11/2005 | US6841566 Viral polymerase inhibitors |
| 01/11/2005 | US6841564 Tri-aryl-substituted-ethane PDE4 inhibitors |
| 01/11/2005 | US6841562 Treatment of gram positive and staphylococcic infections |
| 01/11/2005 | US6841558 Aza-and polyaza-naphthalenyl carboxamides useful as HIV intergrase inhibitors |
| 01/11/2005 | US6841546 Prevention of microorganismal infections; obtain sample of microorganism, incubate with tetracycline compound, monitor propagation of microorganism, reduced propagation indicates effective fungicide |
| 01/11/2005 | US6841545 Heat resistance; anticancer drug |
| 01/11/2005 | US6841530 Semi-synthetic studies toward didemnin analogues |
| 01/11/2005 | US6841381 Immunization by inoculation of DNA transcription unit |
| 01/11/2005 | US6841373 Preparing replication defective viral vector for gene transfer tool; genetic engineering |
| 01/11/2005 | US6841371 Comprises anticoagulant polypeptide for treatment and prevention of acute coronary syndromes, vascular occlusive disorders and thrombosis |
| 01/11/2005 | US6841155 Immunization against and treatment for infection by H. pylori |
| 01/11/2005 | US6841154 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and Staphylococcus aureus |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2248235C Use of honey as an agent to reduce the adhesion of microorganisms |
| 01/07/2005 | CA2470768A1 Crystal structure of osc |
| 01/06/2005 | WO2005001732A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
| 01/06/2005 | WO2005001096A1 Vaccines against sars |
| 01/06/2005 | WO2005000906A1 Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same |
| 01/06/2005 | WO2005000884A1 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
| 01/06/2005 | WO2005000878A2 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 01/06/2005 | WO2005000863A2 6, 11-4c-bicyclic 9a-azalide derivatives |
| 01/06/2005 | WO2005000850A2 Novel crystalline forms of valacyclovir hydrochloride |
| 01/06/2005 | WO2005000843A2 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 01/06/2005 | WO2005000350A1 Medication and method for treating pathological syndrome |
| 01/06/2005 | WO2005000348A2 Vaccines inducing nkt-cell and toll-like-receptor activation |
| 01/06/2005 | WO2005000345A2 Immunization method against neisseria meningitidis serogroups a and c |
| 01/06/2005 | WO2005000324A2 Colloidal silver composition having antimicrobial properties |
| 01/06/2005 | WO2005000308A2 Methods of identifying hcv ns5b polymerase inhibitors and use against hepatitis c |
| 01/06/2005 | WO2005000300A1 Substituted 5-membered ring compounds and their use |
| 01/06/2005 | WO2005000287A1 External preparation for athlete's foot treatment |
| 01/06/2005 | WO2005000266A2 Liposomal formulations comprising a combination of two or more active agents |
| 01/06/2005 | WO2004103336A3 Drug delivery system |
| 01/06/2005 | WO2004096807A3 Hiv integrase inhibitors |
| 01/06/2005 | WO2004089417A9 Drug-enclosing multilayer structure particulate and process for producing the same |
| 01/06/2005 | WO2004089396A3 Anti-fungal peptidomimetics |
| 01/06/2005 | WO2004085478A3 Improved fc fusion proteins |
| 01/06/2005 | WO2004073595A3 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 01/06/2005 | WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/06/2005 | WO1999044608A8 New use |
| 01/06/2005 | US20050004352 Single-chain multiple antigen-binding molecule, its preparation and use |
| 01/06/2005 | US20050004348 Sodium transport protein for use as tool in identifying modulator for treatment of hyperphosphatemia or hypophosphatemia |
| 01/06/2005 | US20050004230 Retroviral protease inhibitors |
| 01/06/2005 | US20050004202 Such as 3-[1-(3-methoxypropyl )-1H-indazol-3-yl]-4-[1-(3-pyridinyl )-1H-indol-3-yl]-1H-pyrrole-2,5-dione; protein kinase C and/or glycogen synthase kinase-3 diseases |
| 01/06/2005 | US20050004192 Inhibiting virus's own RNA-dependent RNA polymerase, NS5B |
| 01/06/2005 | US20050004185 Polyene polyketides, processes for their production and their use as pharmaceuticals |
| 01/06/2005 | US20050004180 Conditions mediated by beta chemokine receptor 2, monocyte chemotactic protein 1 and/or their interaction; such as 4-acetyl-5-cyclohexyl-3-amino-1-(4-methylphenyl)-1,5-dihydro-2H-pyrrol-2-one |
| 01/06/2005 | US20050004148 Human immunodeficiency and hepatitis B infections; high activity, low toxicity |
| 01/06/2005 | US20050004140 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states |
| 01/06/2005 | US20050004132 Pain, immune diseases, inflammatory disorders; low toxicity; such as 1-[2-(3-(4-Pyridyl)phenyl)ethyl]-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine 1-oxide |
| 01/06/2005 | US20050004129 Pyrazole derivatives |
| 01/06/2005 | US20050004125 Such as 4-[[4-(1-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]-benzonitrile; bipolar disorder, pain, type 2 diabetes |
| 01/06/2005 | US20050004120 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004096 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 01/06/2005 | US20050004095 Carbacephem beta-lactam antibiotics |
| 01/06/2005 | US20050004094 Cephem compounds |
| 01/06/2005 | US20050004093 Using 6-betahydroxymethylpenicillanic acid sulfone; bactericides; therapy for bacteria infections in mammals |
| 01/06/2005 | US20050004071 Using sulfated polysaccharides ; therapy for severe acute repiratory syndrome |
| 01/06/2005 | US20050004070 Anti-infectious carbohydrates |
| 01/06/2005 | US20050004061 Immunostimulatory nucleic acid molecules |
| 01/06/2005 | US20050004053 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 01/06/2005 | US20050004047 Bactericides; antiprotozoa agents |
| 01/06/2005 | US20050004040 Peptide having an affinity for gp120 |
| 01/06/2005 | US20050004035 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 01/06/2005 | US20050004011 Compositions and methods for treating bacterial infections with protein-dalbavancin complexes |
| 01/06/2005 | US20050003539 Plasmid maintenance system for antigen delivery |
| 01/06/2005 | US20050003512 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/06/2005 | US20050003453 G-CSF analog compositions and methods |
| 01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
| 01/06/2005 | US20050003409 Expression vector comprising nucleotide sequences coding polyketide synthase for use in transformation, and propagation of streptomyces cells capable of producing moxidectin; bactericides; nematocide |
| 01/06/2005 | US20050002970 Enhancing flowability and lubricity; artificial tears, ocular lubricants |